ARTICLE | Clinical News
Ralinepag: Completed Ph II enrollment
December 13, 2016 10:11 PM UTC
Arena completed enrollment of about 60 patients in a 22-week, double-blind, placebo-controlled, international Phase II trial evaluating oral ralinepag....
BCIQ Company Profiles
BCIQ Target Profiles